This Month's Topics - Health system M&A stays busy across hospitals, ambulatory surgery, and workforce—and AHA pushes to shield deals from expanded FTC scrutiny

Three transactions this month tell a layered story about where dealmaking is headed, and the AHA formally urged the FTC and DOJ to exclude hospital mergers from any revised premerger notification form. Health systems are consolidating along multiple axes—geography, outpatient capacity, and talent supply—while Washington debates how closely to watch.

WVU, Independence merger to help expand services and specialty care access in Western Pennsylvania

West Virginia University (WVU) Health System signed a definitive agreement to absorb Independence Health System, a five-hospital nonprofit in western Pennsylvania that reported a $19.5 million operating loss for fiscal 2025. The deal brings WVU to 30 hospitals with an $800 million, five-year commitment to expand clinical services and modernize Independence facilities. Closing is targeted for late September or early October pending remaining regulatory approvals.

Ascension's AmSurg close shows large ASC plays can survive FTC scrutiny—at a price

Ascension closed its $3.9 billion acquisition of AmSurg, now operating 300 ambulatory surgery centers across 35 states. The FTC required divestiture of seven AmSurg facilities in overlapping markets across Tennessee, Florida, Oklahoma, Texas, and Kansas and appointed a compliance monitor. For systems eyeing large ASC portfolios: regulators may let big ambulatory deals through, with concessions in overlapping markets.

HCA is buying its talent pipeline, not just recruiting from it

HCA agreed to acquire The College of Health Care Professions (CHCP), a Houston-based allied health training provider with 8,000+ students across 10 Texas campuses and online, offering sonography, surgical tech, radiology tech, and other allied health programs. HCA already holds a majority stake in Galen College of Nursing (25 campuses, $300M+ invested since 2020). The pattern is clear: shape the workforce pipeline before graduates hit the open market.

The AHA wants hospitals carved out of expanded antitrust reporting entirely

In formal comments, the AHA argued that proposed HSR form revisions would impose burdens on hospital deals that outweigh any expected benefits, and that the timing is especially damaging given worsening margins, rising expenses, and H.R. 1's impact, all of which make mergers more critical as a financial lifeline for struggling systems. The AHA noted the FTC has filed 15 lawsuits challenging hospital mergers since 2010—and couldn't identify anticompetitive deals that slipped through because of form deficiencies.

So What?

• Health system M&A is diversifying well beyond hospital-absorbs-hospital. Geographic consolidation continues (WVU), but but ASC portfolio acquisitions at Ascension's scale and outright workforce pipeline ownership like HCA's are newer plays that are picking up across the sector. Partners should track all three vectors.

• If the AHA's carveout bid fails and reporting requirements expand, deal timelines and transaction costs will increase—potentially creating less opportunity for both consolidators and struggling systems looking to be acquired.